COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital
22/10/2025
FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix’s investigational intranasal potentiated oxytocin products in patients with Arginine-Vasopressin Deficiency (AVP-D) The [...]
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
22/10/2025
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) [...]
Electra Therapeutics Receives FDA Breakthrough Therapy and EMA Priority Medicines Designations for ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
22/10/2025
ELA026 has demonstrated promising potential as a frontline treatment for patients with sHLH, a hyperinflammatory disease with high mortality and significant unmet medical need Electra has initiated the SURPASS global [...]
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
22/10/2025
SAN FRANCISCO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Appili Therapeutics to Attend BARDA Innovation Symposium 2025
22/10/2025
Highlights Government-Funded Pipeline and Expanding Role of Public-Private Partnerships in Biodefense Innovation HALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTC Pink: [...]
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
22/10/2025
Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (“ProPhase” or the [...]
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
22/10/2025
Appointment reinforces ProMIS Neurosciences’ strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer’s program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE [...]
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025
22/10/2025
Dapirolizumab pegol (DZP) Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease activity/remission, flares, fatigue, joint pain and quality of life [...]
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
22/10/2025
Independent DSMB has identified no safety concerns, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor Fourth consecutive positive DSMB recommendation supports [...]
DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes
22/10/2025
Strategic Alliance Targets Digital Transformation of the $634.32 Billion (1) US Prescription Drug Market Through Blockchain-Enabled Data Monetization and AI-Driven Efficiency Gains BEAVERTON, OR, Oct. 22, 2025 (GLOBE [...]
Holland Foundation for Sight Restoration Launches Light After Darkness Fundraising Campaign
22/10/2025
The $5M Light After Darkness campaign to empower surgeons, advance care, and drive research innovation CINCINNATI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Holland Foundation for Sight Restoration , the only foundation in [...]
TerrAscend Reschedules November 6th Third Quarter 2025 Earnings Conference Call to Pre-Open from Post-Market Close
22/10/2025
TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis company, today announced that it has rescheduled its November 6 [...]
Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine
22/10/2025
SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, [...]
LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program
22/10/2025
Renowned Menopause and Hormone Specialist to Help Guide and Represent LifeMD’s Comprehensive and Personalized Care Offering for Women NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading [...]
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
22/10/2025
STOUGHTON, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have poster presentations highlighting real-world data from its differentiated neuropsychiatry [...]
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
22/10/2025
Aardvark to host Investor Webinar with members of the management team, leading key opinion leaders and patient advocates on November 5, 2025 SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. ( [...]
R1 Launches Phare, Healthcare’s First Revenue Operating System
22/10/2025
Delivers on R1’s Long-Term Investments in People and Technology to Transform the Revenue Cycle Through Sustained, AI-Driven Innovation R1 Enters Exclusive Partnership with Singing River Health System to Implement Phare [...]
DLH Demonstrates Cybersecurity Excellence with CMMC Level 2 Certification
22/10/2025
ATLANTA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
Alignment Health Plan Named a 2026 Best Insurance Company for Medicare Advantage Across All Its Markets by U.S. News & World Report
22/10/2025
Company earns “Best” ranking in Arizona, California, Nevada, North Carolina and Texas, reflecting strong performance in care quality, prevention and satisfaction ORANGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- [...]

Pages